In terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct to regulate, monitor and report trading by designated persons & immediate relatives of Designated Persons, Jagsonpal Pharmaceuticals has informed that the Trading Window for dealing in securities of the company shall remain closed for Designated Persons and their immediate relative(s) with effect from Wednesday, October 01, 2025 till the end of 48 hours after the declaration of Un- Audited Financial Results for the quarter and half year ended September 30, 2025. The date of Board Meeting for declaration of Un-Audited financial results of the Company for the quarter and half year ended on 30th September, 2025 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
